News from the healthcare data industry
CHICAGO and SCOTTSDALE, Ariz., April 14, 2022 /PRNewswire/ — EVERSANA™, the pioneer of next-generation commercial services to the global life sciences industry, and UpScriptHealth™, the leading telehealth and virtual prescribing platform serving life sciences companies, today announced...
People with different ancestries inherit different risks and encounter different environmental exposures resulting in different somatic profiles. Research Presented at the American Association for Cancer Research (AACR) Annual Meeting, held...
Harriet Unsworth outlines her role in updating our evidence standards framework for digital health technologies. She also explains how you can share your views as part of our consultation. 12...
The NICE Strategy 2021 to 2026 states our ambition to use real-world data to resolve gaps in knowledge and drive forward access to innovations for patients. To help deliver on...
April 13, 2022 09:50 AM Eastern Daylight Time DALLAS–(BUSINESS WIRE)–Texas Oncology announced today that it has entered into an agreement with Foundation Medicine, a pioneer in molecular profiling for cancer,...
April 13, 2022 Michael Vasconcelles, MD, Brad Jordan, PhD Evidence-Based Oncology, April 2022, Volume 28, Issue 3Pages: SP142-SP143 Recent steps by FDA to promote the use of real-world evidence are to be commended, but...
– Medical chart review study, published in Drugs in Context, evaluated the real-world use of INOmax® (nitric oxide) gas, for inhalation in hospitalized COVID-19 patients with mild-to-moderate acute respiratory distress syndrome (ARDS) in...
Pertuzumab combined with trastuzumab, and docetaxel revealed comparable survival outcomes with previous studies of patients with metastatic breast cancer, including the CLEOPATRA trial. A real-world analysis evaluating the triplet regimen...
ABSTRACT BACKGROUND: It is not known whether sotrovimab, a neutralizing monoclonal antibody (mAb) treatment authorized for early symptomatic COVID-19 patients, is effective against the SARS-CoV-2 Delta variant to prevent progression...
LinkDoc Technology Limited, a Chinese medical big data company, announced on Monday that it has withdrawn its application for a public listing in the United States. In June 2021, LinkDoc...